Lance Wilkes, U.S. healthcare services analyst at Bernstein, discusses why despite the mounting issues facing UnitedHealth ...

UnitedHealth is almost as oversold as during the Great Financial Crisis, with its monthly RSI sitting at 33. Find out why UNH ...

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic ...

The reported probe adds to a string of recent setbacks that have erased more than half, or over $300 billion, from its market ...

Stephen Hemsley would get stock options after three years, in some cases even if he doesn’t stay that long ...

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.

It keeps getting worse for UnitedHealth Group Inc. investors, as a report of a criminal investigation into its Medicare ...

UnitedHealth shares dropped 55%, facing lawsuits and claim rejection issues. Management changes raise questions on recovery.

Stephen Hemsley hasn’t been CEO at UnitedHealth Group in nearly a decade yet he’s never really left. Hemsley, 72, has ...

Shares of UnitedHealth Group plunged more than 18% following a report that the Department of Justice is carrying out a ...

Shares of UnitedHealth Group tumbled 16% in intraday trading Thursday, leading S&P 500 decliners, on a report that the U.S.

The U.S. Department of Justice is carrying out a criminal investigation into UnitedHealth Group for possible Medicare fraud, ...